Investments
304Portfolio Exits
61Funds
8Service Providers
1About Prism VentureWorks
Founded in 1995 with $1.25 billion under management over five investment funds, Prism VentureWorks is a venture capital firm focused on investments in information technology, life sciences and digital living. The firm has 14 investment professionals and maintains offices in Massachusetts (Needham) and California (Venice).

Want to inform investors similar to Prism VentureWorks about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Prism VentureWorks News
Dec 3, 2013
By FinSMEs Xlumena , a Mountain View, CA-based developer of advanced endoscopic devices, closed $25m in Series C financing. The round was led by Third Point, with participation from existing investors Prism VentureWorks, Charter Life Sciences, Ascent Biomedical Ventures and Aperture Venture Partners. In conjunction with the funding, Jason Hong Ph.D. of Third Point LLC, will join Xlumena’s Board of Directors. The company intends to use the funds to expand global commercialization efforts for its AXIOS family of devices and continue to bring its platform to the US interventional endoscopy community. Led by Greg Patterson, President and CEO, Xlumena provides the AXIOS Stent and Delivery System, which obtained a CE mark designation in Europe in 2012 and is available in a select number of centers. The AXIOS Stent, a fully-covered, dual-flanged stent, is delivered under endoscopic ultrasound guidance and designed to create a secure drainage pathway between the gastrointestinal tract and the common bile duct, gallbladder or pseudocyst. The HOT AXIOS, also available in Europe, incorporates cautery into the delivery system, enabling access and stent delivery in a single device. The AXIOS devices have been used in the treatment of acute cholecystitis, biliary inflammation associated with strictures or stones in the bile duct, and pancreatic pseudocysts. FinSMEs
Prism VentureWorks Investments
304 Investments
Prism VentureWorks has made 304 investments. Their latest investment was in ClearIt as part of their Unattributed VC on July 7, 2022.

Prism VentureWorks Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
7/28/2022 | Unattributed VC | ClearIt | $0.03M | Yes | Prism VentureWorks, and Undisclosed Investors | 1 |
11/3/2020 | Series B | Neuros Medical | $38.5M | No | 3 | |
9/24/2020 | Series A | Babson Diagnostics | $13.7M | Yes | 11 | |
8/3/2020 | Unattributed VC | |||||
1/9/2020 | Series B |
Date | 7/28/2022 | 11/3/2020 | 9/24/2020 | 8/3/2020 | 1/9/2020 |
---|---|---|---|---|---|
Round | Unattributed VC | Series B | Series A | Unattributed VC | Series B |
Company | ClearIt | Neuros Medical | Babson Diagnostics | ||
Amount | $0.03M | $38.5M | $13.7M | ||
New? | Yes | No | Yes | ||
Co-Investors | Prism VentureWorks, and Undisclosed Investors | ||||
Sources | 1 | 3 | 11 |
Prism VentureWorks Portfolio Exits
61 Portfolio Exits
Prism VentureWorks has 61 portfolio exits. Their latest portfolio exit was Venus Concept (Merged with Restoration Robotics) on November 07, 2019.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
11/7/2019 | Merger | 5 | |||
2/14/2019 | IPO | Public | 3 | ||
2/12/2019 | Acquired | 2 | |||
Date | 11/7/2019 | 2/14/2019 | 2/12/2019 | ||
---|---|---|---|---|---|
Exit | Merger | IPO | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 5 | 3 | 2 |
Prism VentureWorks Acquisitions
1 Acquisition
Prism VentureWorks acquired 1 company. Their latest acquisition was Epicon on June 18, 1998.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
6/18/1998 | Other | $30M | Acquired |
Date | 6/18/1998 |
---|---|
Investment Stage | Other |
Companies | |
Valuation | |
Total Funding | $30M |
Note | Acquired |
Sources |
Prism VentureWorks Fund History
8 Fund Histories
Prism VentureWorks has 8 funds, including Prism Venture Partners V LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
6/19/2005 | Prism Venture Partners V LP | Early-Stage Venture Capital | Closed | $172M | 1 |
5/4/2005 | Prism Venture Partners V-A LP | ||||
2/28/2002 | Prism Venture Partners II-A | ||||
1/31/2002 | Prism Venture Partners IV LP | ||||
3/27/2000 | Prism Venture Partners III LP |
Closing Date | 6/19/2005 | 5/4/2005 | 2/28/2002 | 1/31/2002 | 3/27/2000 |
---|---|---|---|---|---|
Fund | Prism Venture Partners V LP | Prism Venture Partners V-A LP | Prism Venture Partners II-A | Prism Venture Partners IV LP | Prism Venture Partners III LP |
Fund Type | Early-Stage Venture Capital | ||||
Status | Closed | ||||
Amount | $172M | ||||
Sources | 1 |
Prism VentureWorks Service Providers
1 Service Provider
Prism VentureWorks has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
---|---|---|---|
Counsel | General Counsel |
Service Provider | |
---|---|
Associated Rounds | |
Provider Type | Counsel |
Service Type | General Counsel |
Partnership data by VentureSource
Prism VentureWorks Team
13 Team Members
Prism VentureWorks has 13 team members, including , .
Name | Work History | Title | Status |
---|---|---|---|
John L Brooks III | NeuroBo Pharmaceuticals, Pittsburgh Life Sciences Greenhouse, Joslin Diabetes Center, Valleylab, Pfizer, Arthur Andersen, MedCap Advisors, and Ansaris | Founder | Current |
Name | John L Brooks III | ||||
---|---|---|---|---|---|
Work History | NeuroBo Pharmaceuticals, Pittsburgh Life Sciences Greenhouse, Joslin Diabetes Center, Valleylab, Pfizer, Arthur Andersen, MedCap Advisors, and Ansaris | ||||
Title | Founder | ||||
Status | Current |